Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
Dr Reddy's global generic business grew 19 per cent YoY to Rs 4,743 crore driven by covid portfolio, new product launches and base business volume traction across key markets.
Dr Reddy's global generic business grew 19 per cent YoY to Rs 4,743 crore driven by covid portfolio, new product launches and base business volume traction across key markets. https://ift.tt/3EsXDNW October 28, 2021 at 10:51PM
Dr Reddy's global generic business grew 19 per cent YoY to Rs 4,743 crore driven by covid portfolio, new product launches and base business volume traction across key markets. https://ift.tt/3EsXDNW October 28, 2021 at 10:51PM
Comments
Post a Comment